<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Northstar Stocks</title>
	<atom:link href="http://www.northstarstocks.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.northstarstocks.com</link>
	<description>Communication and Disclosure Management</description>
	<lastBuildDate>Sun, 29 Jan 2012 22:58:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>[OTC:GYST] The Graystone Company (GYST) Announces Assay Results From Gorilla Gold Deposits</title>
		<link>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-gyst-announces-assay-results-from-gorilla-gold-deposits/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-gyst-announces-assay-results-from-gorilla-gold-deposits/#comments</comments>
		<pubDate>Sun, 29 Jan 2012 22:24:53 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks News]]></category>
		<category><![CDATA[gold claim]]></category>
		<category><![CDATA[gorilla]]></category>
		<category><![CDATA[graystone inc]]></category>
		<category><![CDATA[GYST]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[OTC]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=14075</guid>
		<description><![CDATA[The Graystone Company (GYST) Announces Assay Results From Gorilla Gold Deposits &#160; Symbol Price Change GYST.OB 0.22 0.00 LIMA, Peru&#8211;(BUSINESS WIRE)&#8211;The Graystone Company (OTCBB: GYST), announced today its results from the Company&#8217;s recently completed preliminary study at the Company&#8217;s mining project Gorilla in Peru. The preliminary study is designed to expand and update the Company&#8217;s [...]]]></description>
			<content:encoded><![CDATA[<div>
<div>
<h1>The Graystone Company (GYST) Announces Assay Results From Gorilla Gold Deposits</h1>
<p>&nbsp;</p>
</div>
</div>
<div id="yui_3_3_0_1_1327860866803172">
<div>
<div id="mediarelatedquotes">
<div>
<table id="yui_3_3_0_6_1327860866803468">
<thead id="yui_3_3_0_6_1327860866803575">
<tr id="yui_3_3_0_6_1327860866803574">
<th>Symbol</th>
<th>Price</th>
<th id="yui_3_3_0_6_1327860866803573">Change</th>
</tr>
</thead>
<tbody id="yui_3_3_0_6_1327860866803578">
<tr id="yui_3_3_0_6_1327860866803470">
<td><a  href="/q?s=gyst.ob">GYST.OB</a></td>
<td>0.22</td>
<td id="yui_3_3_0_6_1327860866803577">0.00</td>
</tr>
<tr id="yui_3_3_0_6_1327860866803581">
<td id="yui_3_3_0_6_1327860866803580" colspan="3">
<div id="yui_3_3_0_6_1327860866803585"><a  id="yui_3_3_0_6_1327860866803584" href="/q?s=gyst.ob"><img id="yui_3_3_0_6_1327860866803583" title="" src="http://ichart.finance.yahoo.com/t?s=gyst.ob&amp;lang=en-US&amp;region=us" alt="" /></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
<div id="yui_3_3_0_1_1327860866803171">
<div id="yui_3_3_0_1_1327860866803170">
<div id="yui_3_3_0_1_1327860866803169">
<p>LIMA, Peru&#8211;(BUSINESS WIRE)&#8211;The Graystone Company (OTCBB: GYST), announced today its results from the Company&#8217;s recently completed preliminary study at the Company&#8217;s mining project Gorilla in Peru. The preliminary study is designed to expand and update the Company&#8217;s inferred gold resources and to begin mapping the mineralization of the gold on the property.</p>
<p>The results of the mapping will assist in identifying high priority mining targets once the Company begins limited production (or bulk sampling), planned for the late fall of 2012.</p>
<p>The Company&#8217;s Managing Director, Paul Howarth, will be in Peru for the month of February to retain an additional geologist in Peru who will assist in the mineralization map. The Company expects the mineralization map to take at least 7-12 months to complete. During this time, the Company is also beginning the construction on a new mining camp on Gorilla to prepare for additional operations to commence once the       mineralization map has been completed.</p>
<p>A summary of the results of the prefeasibility study are as follows:</p>
<table cellspacing="0">
<tbody>
<tr>
<td rowspan="2">          Code</td>
<td></td>
<td></td>
<td></td>
<td colspan="5">          Coordinates</td>
<td></td>
<td></td>
<td></td>
<td rowspan="2">
<div>            Cubic<br />
Meters<br />
Mined</div>
</td>
<td></td>
<td></td>
<td></td>
<td rowspan="2">
<div>            Gold per<br />
cubic meter</div>
</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td>          North</td>
<td></td>
<td></td>
<td></td>
<td>          East</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>          GS001GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507110</td>
<td></td>
<td></td>
<td></td>
<td>          223040</td>
<td></td>
<td></td>
<td></td>
<td>          10m</td>
<td></td>
<td></td>
<td></td>
<td>          0.8</td>
</tr>
<tr>
<td>          GS002GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507320</td>
<td></td>
<td></td>
<td></td>
<td>          223002</td>
<td></td>
<td></td>
<td></td>
<td>          13m</td>
<td></td>
<td></td>
<td></td>
<td>          0.61</td>
</tr>
<tr>
<td>          GS003GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507867</td>
<td></td>
<td></td>
<td></td>
<td>          223129</td>
<td></td>
<td></td>
<td></td>
<td>          9m</td>
<td></td>
<td></td>
<td></td>
<td>          0.94</td>
</tr>
<tr>
<td>          GS004GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507873</td>
<td></td>
<td></td>
<td></td>
<td>          223126</td>
<td></td>
<td></td>
<td></td>
<td>          21m</td>
<td></td>
<td></td>
<td></td>
<td>          0.76</td>
</tr>
<tr>
<td>          GS005GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507090</td>
<td></td>
<td></td>
<td></td>
<td>          223025</td>
<td></td>
<td></td>
<td></td>
<td>          28m</td>
<td></td>
<td></td>
<td></td>
<td>          1.2</td>
</tr>
<tr>
<td>          GS006GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507055</td>
<td></td>
<td></td>
<td></td>
<td>          223022</td>
<td></td>
<td></td>
<td></td>
<td>          17m</td>
<td></td>
<td></td>
<td></td>
<td>          1.24</td>
</tr>
<tr>
<td>          GS007GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507040</td>
<td></td>
<td></td>
<td></td>
<td>          222998</td>
<td></td>
<td></td>
<td></td>
<td>          22m</td>
<td></td>
<td></td>
<td></td>
<td>          0.68</td>
</tr>
<tr>
<td>          GS008GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507015</td>
<td></td>
<td></td>
<td></td>
<td>          223004</td>
<td></td>
<td></td>
<td></td>
<td>          29m</td>
<td></td>
<td></td>
<td></td>
<td>          0.55</td>
</tr>
<tr>
<td>          GS009GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507350</td>
<td></td>
<td></td>
<td></td>
<td>          223008</td>
<td></td>
<td></td>
<td></td>
<td>          34m</td>
<td></td>
<td></td>
<td></td>
<td>          0.52</td>
</tr>
<tr>
<td>          GS0010GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507842</td>
<td></td>
<td></td>
<td></td>
<td>          223092</td>
<td></td>
<td></td>
<td></td>
<td>          38m</td>
<td></td>
<td></td>
<td></td>
<td>          0.447</td>
</tr>
<tr>
<td>          GS0011GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507607</td>
<td></td>
<td></td>
<td></td>
<td>          223007</td>
<td></td>
<td></td>
<td></td>
<td>          12m</td>
<td></td>
<td></td>
<td></td>
<td>          0.33</td>
</tr>
<tr>
<td>          GS0012GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507580</td>
<td></td>
<td></td>
<td></td>
<td>          223011</td>
<td></td>
<td></td>
<td></td>
<td>          10m</td>
<td></td>
<td></td>
<td></td>
<td>          0.4</td>
</tr>
<tr>
<td>          GS0013GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507252</td>
<td></td>
<td></td>
<td></td>
<td>          223005</td>
<td></td>
<td></td>
<td></td>
<td>          26m</td>
<td></td>
<td></td>
<td></td>
<td>          0.96</td>
</tr>
<tr>
<td>          GS0014GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507871</td>
<td></td>
<td></td>
<td></td>
<td>          223105</td>
<td></td>
<td></td>
<td></td>
<td>          15m</td>
<td></td>
<td></td>
<td></td>
<td>          1.16</td>
</tr>
<tr>
<td>          GS0015GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507852</td>
<td></td>
<td></td>
<td></td>
<td>          223098</td>
<td></td>
<td></td>
<td></td>
<td>          17m</td>
<td></td>
<td></td>
<td></td>
<td>          1.05</td>
</tr>
<tr>
<td>          GS0016GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507543</td>
<td></td>
<td></td>
<td></td>
<td>          222998</td>
<td></td>
<td></td>
<td></td>
<td>          26m</td>
<td></td>
<td></td>
<td></td>
<td>          0.46</td>
</tr>
<tr>
<td>          GS0017GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507280</td>
<td></td>
<td></td>
<td></td>
<td>          223015</td>
<td></td>
<td></td>
<td></td>
<td>          19m</td>
<td></td>
<td></td>
<td></td>
<td>          1.47</td>
</tr>
<tr>
<td>          GS0018GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507075</td>
<td></td>
<td></td>
<td></td>
<td>          223027</td>
<td></td>
<td></td>
<td></td>
<td>          10m</td>
<td></td>
<td></td>
<td></td>
<td>          1.3</td>
</tr>
<tr>
<td>          GS0019GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507844</td>
<td></td>
<td></td>
<td></td>
<td>          223090</td>
<td></td>
<td></td>
<td></td>
<td>          27m</td>
<td></td>
<td></td>
<td></td>
<td>          0.55</td>
</tr>
<tr>
<td>          GS0020GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507486</td>
<td></td>
<td></td>
<td></td>
<td>          223003</td>
<td></td>
<td></td>
<td></td>
<td>          23m</td>
<td></td>
<td></td>
<td></td>
<td>          0.43</td>
</tr>
<tr>
<td>          GS0021GO</td>
<td></td>
<td></td>
<td></td>
<td>          9507210</td>
<td></td>
<td></td>
<td></td>
<td>          222995</td>
<td></td>
<td></td>
<td></td>
<td>          16m</td>
<td></td>
<td></td>
<td></td>
<td>          0.81</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p><strong>About The Graystone Company</strong> The Graystone Company, Inc. is a U.S.-based mining and exploration company focused on acquiring and developing gold and other mineral properties. The Company&#8217;s strategy is to build value for shareholders by the identification, acquisition and exploration of early-stage properties that show significant potential for the discovery of gold.</p>
<p><strong>Notice Regarding Forward-Looking Statements</strong> in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.</p>
<p>&nbsp;</p>
<div>
<div>Contact:</div>
<div>The Graystone Company, Inc.<br />
Paul Howarth<br />
(702) 438-4100<br />
<a  href="mailto:info@graystone1.com">info@graystone1.com</a><br />
<a  href="http://www.graystone1.com">www.graystone1.com</a></div>
</div>
</div>
</div>
<div id="mediasocialfollow">
<div></div>
</div>
<p>&nbsp;</p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-gyst-announces-assay-results-from-gorilla-gold-deposits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[OTC:GYST] The Graystone Company (GYST) Announces Shareholder Precious Metal Purchase Program</title>
		<link>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-gyst-announces-shareholder-precious-metal-purchase-program/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-gyst-announces-shareholder-precious-metal-purchase-program/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 15:06:10 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks News]]></category>
		<category><![CDATA[gold prices]]></category>
		<category><![CDATA[gorilla]]></category>
		<category><![CDATA[graystone inc]]></category>
		<category><![CDATA[GYST]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[OTC]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=14069</guid>
		<description><![CDATA[The Graystone Company (GYST) Announces Shareholder Precious Metal Purchase Program Symbol Price Change GYST.OB 0.315 0.00 LAS VEGAS–(BUSINESS WIRE)–The Graystone Company (OTCBB: GYST), announced today that it is creating a shareholder precious metal purchase program. Under the program, qualified shareholders may purchase precious metals from the Company at near spot prices. To qualify a person [...]]]></description>
			<content:encoded><![CDATA[<h1>The Graystone Company (GYST) Announces Shareholder Precious Metal Purchase Program</h1>
<div id="yui_3_3_0_1_1326894747890173">
<div>
<div id="mediarelatedquotes">
<div>
<table id="yui_3_3_0_7_1326894747890466">
<thead>
<tr>
<th>Symbol</th>
<th>Price</th>
<th>Change</th>
</tr>
</thead>
<tbody>
<tr id="yui_3_3_0_7_1326894747890468">
<td><a href="http://www.northstarstocks.com/wp-content/plugins/mailpress/mp-includes/action.php?tg=l&amp;mm=1750&amp;co=h&amp;us={{_confkey}}">GYST.OB</a></td>
<td>0.315</td>
<td>0.00</td>
</tr>
<tr>
<td colspan="3">
<div><a href="http://www.northstarstocks.com/wp-content/plugins/mailpress/mp-includes/action.php?tg=l&amp;mm=1750&amp;co=h&amp;us={{_confkey}}"><img title="" src="http://ichart.finance.yahoo.com/t?s=gyst.ob&amp;lang=en-US&amp;region=us" alt="" /></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
<div id="yui_3_3_0_1_1326894747890172">
<div id="yui_3_3_0_1_1326894747890171">
<div id="yui_3_3_0_1_1326894747890170">
<p>LAS VEGAS–(BUSINESS WIRE)–The Graystone Company (OTCBB: GYST), announced today that it is creating a shareholder precious metal purchase program. Under the program, qualified shareholders may purchase precious metals from the Company at near spot prices. To qualify a person must be a shareholder of record at the time of purchase and own at least 5,000 shares of the Company’s common stock.</p>
<p>Shareholders can download and print a Shareholder Purchase Request Form from the Company’s website: <a href="http://www.northstarstocks.com/wp-content/plugins/mailpress/mp-includes/action.php?tg=l&amp;mm=1751&amp;co=h&amp;us={{_confkey}}">www.graystonegold.com</a>.</p>
<p>At least once a month the Company will publicly announce a product to be sold to the shareholders. The product will be limited in number and will be shipped on a first come first serve basis.</p>
<p>The Company’s initial product under the program is as follows:</p>
<table cellspacing="0">
<tbody>
<tr>
<td>
<div><strong>Product</strong></div>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>
<div><strong>Price</strong></div>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>
<div><strong>Quantity</strong></div>
</td>
</tr>
<tr>
<td>          1 Ounce Silver Bar/Round</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>          $31.00</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>          20</td>
</tr>
</tbody>
</table>
<p>The price above does not reflect shipping charge of $7.99. Any shareholder who pays by credit card will incur a fee of 2.9%.</p>
<p><strong>About The Graystone Company.</strong> The Graystone Company, Inc. is a U.S.-based mining and exploration company focused on acquiring and developing gold and other mineral properties. The Company’s strategy is to build value for shareholders by the identification, acquisition and exploration of early-stage properties that show significant potential for the discovery of gold.</p>
<p><strong>Notice Regarding Forward-Looking Statements</strong> in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.</p>
<p>&nbsp;</p>
<div id="yui_3_3_0_1_1326894747890169">
<div>Contact:</div>
<div>The Graystone Company, Inc.<br />
Paul Howarth, 702-438-4100</div>
<div><a  href="mailto:info@graystone1.com">info@graystone1.com</a><br />
<a href="http://www.northstarstocks.com/wp-content/plugins/mailpress/mp-includes/action.php?tg=l&amp;mm=1752&amp;co=h&amp;us={{_confkey}}">www.graystone1.com</a>Please read our full Disclaimer here: <a  href="http://www.northstarstocks.com/disclaimer/">http://www.northstarstocks.com/disclaimer/</a><br />
Northstarstocks.com expects to be compensated by a third party for The Graystone Company [OTC:GYST] advertising services.</p>
</div>
</div>
</div>
</div>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-gyst-announces-shareholder-precious-metal-purchase-program/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[OTC:GYST] The Graystone Company Announces Launch of Retail Gold and Precious Metals Division</title>
		<link>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-launch-of-retail-gold-and-precious-metals-division/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-launch-of-retail-gold-and-precious-metals-division/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 14:17:13 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks News]]></category>
		<category><![CDATA[gold claim]]></category>
		<category><![CDATA[gold prices]]></category>
		<category><![CDATA[GYST]]></category>
		<category><![CDATA[mining]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=14064</guid>
		<description><![CDATA[The Graystone Company (GYST) Announces Launch of Retail Gold and Precious Metals Division Symbol Price Change GYST.OB 0.28 0.00 LAS VEGAS&#8211;(BUSINESS WIRE)&#8211;The Graystone Company (OTC Bulletin Board: GYST), announced today that it has launched its retail gold and precious metals division, Graystone Gold and Precious Metals. The division will be selling precious metals directly to [...]]]></description>
			<content:encoded><![CDATA[<div>
<div>
<h1>The Graystone Company (GYST) Announces Launch of Retail Gold and Precious Metals Division</h1>
</div>
</div>
<div id="yui_3_3_0_1_1326807828805169">
<div>
<div id="mediarelatedquotes">
<div>
<table id="yui_3_3_0_7_1326807828805476">
<thead>
<tr>
<th>Symbol</th>
<th>Price</th>
<th>Change</th>
</tr>
</thead>
<tbody>
<tr id="yui_3_3_0_7_1326807828805478">
<td><a  href="/q?s=gyst.ob">GYST.OB</a></td>
<td>0.28</td>
<td>0.00</td>
</tr>
<tr>
<td colspan="3">
<div><a  href="/q?s=gyst.ob"><img title="" src="http://ichart.finance.yahoo.com/t?s=gyst.ob&amp;lang=en-US&amp;region=us" alt="" /></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
<div id="yui_3_3_0_1_1326807828805168">
<div id="yui_3_3_0_1_1326807828805167">
<div>
<p>LAS VEGAS&#8211;(BUSINESS WIRE)&#8211;<a  href="http://us.lrd.yahoo.com/SIG=177kg387h/EXP=1328017426/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fwww.graystone1.com%252F%26esheet=50134881%26lan=en-US%26anchor=The%2BGraystone%2BCompany%26index=1%26md5=e561dfadf12c58880e174a2d291f7135">The Graystone Company</a> (OTC Bulletin Board: <a  href="http://us.lrd.yahoo.com/SIG=17h1l19a2/EXP=1328017426/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Ffinance.yahoo.com%252Fq%253Fs%253DGYST.OB%2526ql%253D1%26esheet=50134881%26lan=en-US%26anchor=GYST%26index=2%26md5=dbed0d53e55a53d8c9864243cc89db6a">GYST</a>), announced today that it has launched its retail gold and precious metals division, <a  href="http://us.lrd.yahoo.com/SIG=17mjkkqth/EXP=1328017426/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fwww.graystonegold.com%26esheet=50134881%26lan=en-US%26anchor=Graystone%2BGold%2Band%2BPrecious%2BMetals%26index=3%26md5=48e1dfa5f42c8b2115a537d339c7ae6e">Graystone Gold and Precious Metals</a>. The division will be selling precious metals directly to consumers through its website <a  href="http://us.lrd.yahoo.com/SIG=171333ii0/EXP=1328017426/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fwww.GraystoneGold.com%26esheet=50134881%26lan=en-US%26anchor=www.GraystoneGold.com%26index=4%26md5=4c1eb80714ec665f18aad3098be4670d">www.GraystoneGold.com</a>. The Company will initially focus on selling gold and silver bullion.</p>
<p>The Company intends to vertically integrate its business from producing gold and precious metals from its own mines to being able to sell directly to consumers and jewelers. Selling gold and silver through its retail division allows the company to increases its margins by 15-20%. Junior mining companies typically sell its ore to refineries for 5-7% below spot price. However, by selling it retail the Company can sell the gold and other precious metals for 10-15% over spot (for an increase of up to 20%). For example, the increase in margins could generate an additional $300 per ounce of gold.</p>
<p>The Company will initially purchase gold and the other precious metals from wholesale sources until the Company&#8217;s mining operations begin producing sufficient ore.</p>
<p>&#8220;This is just our first step in vertically integrating our business, &#8220;said Paul Howarth, managing director of The Graystone Company. &#8220;Our       focus is to bring our mining operations online and to generate revenue as quickly as possible. The retail division allows the Company to begin       generating revenue almost immediately. We expect to grow the retail business over the next 8-12 months while we are building out our mining       operations. At which time, we can begin selling the gold and silver we produce directly to consumers and jewelers.&#8221;</p>
<p>The division&#8217;s website is still in its beta testing phase and expects to  go live on February 1, 2012. During the beta testing phase, the Company will limit its transactions to 1 ounce silver, 1 gram gold and 1 ounce gold bars.</p>
<p><strong>About The Graystone Company.</strong> The Graystone Company, Inc. is a U.S.-based mining and exploration company focused on acquiring and developing gold and other mineral properties. The Company&#8217;s strategy is to build value for shareholders by the identification, acquisition and exploration of early-stage properties that show significant potential for the discovery of gold.</p>
<p><strong>Notice Regarding Forward-Looking Statements</strong> in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the       date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information  set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.</p>
<div>
<div>Contact:</div>
<div>The Graystone Company, Inc.<br />
Paul Howarth, 702-438-4100<br />
<a  href="mailto:info@graystone1.com">info@graystone1.com</a><br />
<a  href="http://us.lrd.yahoo.com/SIG=170k930b8/EXP=1328017426/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fwww.graystone1.com%252F%26esheet=50134881%26lan=en-US%26anchor=www.graystone1.com%26index=5%26md5=b819acfebcbf1bac0421b5f38c8c7fcd">www.graystone1.com</a><br />
<a  href="http://www.graystonegold.com">www.graystonegold.com</a></div>
<div>
<p>Please read our full Disclaimer here: <a  href="http://www.northstarstocks.com/disclaimer/">http://www.northstarstocks.com/disclaimer/</a><br />
Northstarstocks.com expects to be compensated by a third party for The Graystone Company [OTC:GYST] advertising services.</p>
</div>
</div>
</div>
</div>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-launch-of-retail-gold-and-precious-metals-division/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[OTC:GYST] The Graystone Company Announces Its Bulk Sampling on Gorilla Indicate Possibility of 500,000 Ounces of Gold</title>
		<link>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-its-bulk-sampling-on-gorilla-indicate-possibility-of-500000-ounces-of-gold/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-its-bulk-sampling-on-gorilla-indicate-possibility-of-500000-ounces-of-gold/#comments</comments>
		<pubDate>Thu, 12 Jan 2012 13:50:42 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks News]]></category>
		<category><![CDATA[gold claim]]></category>
		<category><![CDATA[gold prices]]></category>
		<category><![CDATA[gorilla]]></category>
		<category><![CDATA[GYST]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=14061</guid>
		<description><![CDATA[The Graystone Company Announces Its Bulk Sampling on Gorilla Indicate Possibility of 500,000 Ounces of Gold Symbol Price Change GYST.OB 0.275 0.00 &#160; LIMA, Peru&#8211;(BUSINESS WIRE)&#8211; The Graystone Company (OTCQB: GYST), announced today that the Company conducted 23 days of test mining production (&#8220;bulk sampling&#8221;) on its claim &#8220;Gorilla.&#8221; Based on the results, the Company has estimated [...]]]></description>
			<content:encoded><![CDATA[<div>
<div>
<h1>The Graystone Company Announces Its Bulk Sampling on Gorilla Indicate Possibility of 500,000 Ounces of Gold</h1>
</div>
</div>
<div>
<div>
<div id="mediarelatedquotes">
<div>
<table id="yui_3_3_0_7_1326375547563468">
<thead>
<tr>
<th>Symbol</th>
<th>Price</th>
<th>Change</th>
</tr>
</thead>
<tbody id="yui_3_3_0_7_1326375547563552">
<tr id="yui_3_3_0_7_1326375547563470">
<td><a  href="/q?s=gyst.ob">GYST.OB</a></td>
<td id="yui_3_3_0_7_1326375547563551">0.275</td>
<td>0.00</td>
</tr>
<tr id="yui_3_3_0_7_1326375547563556">
<td id="yui_3_3_0_7_1326375547563555" colspan="3">
<div id="yui_3_3_0_7_1326375547563560"><a  id="yui_3_3_0_7_1326375547563559" href="/q?s=gyst.ob"><img id="yui_3_3_0_7_1326375547563558" title="" src="http://ichart.finance.yahoo.com/t?s=gyst.ob&amp;lang=en-US&amp;region=us" alt="" /></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
<p>&nbsp;</p>
</div>
<div>
<div>
<div>
<p>LIMA, Peru&#8211;(BUSINESS WIRE)&#8211; <a  href="http://us.lrd.yahoo.com/SIG=172urkcak/EXP=1327585145/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fwww.graystone1.com%26esheet=50131325%26lan=en-US%26anchor=The%2BGraystone%2BCompany%26index=1%26md5=d5f540b7d11288bc0d54cac3c83a8fc9">The Graystone Company</a> (OTCQB: <a  href="http://us.lrd.yahoo.com/SIG=17oh1odeo/EXP=1327585145/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fih.advfn.com%252Fp.php%253Fpid%253Dsquote%2526symbol%253Dgyst%26esheet=50131325%26lan=en-US%26anchor=GYST%26index=2%26md5=a075a9c6b9183d0e792db7bad2d3cc9d">GYST</a>), announced today that the Company conducted 23 days of test mining production (&#8220;bulk sampling&#8221;) on its claim &#8220;Gorilla.&#8221;</p>
<p>Based on the results, the Company has estimated that the average level of gold on Gorilla is 0.76 grams per cubic meter. The results from the       23 days ranged from 0.33 grams per meter<sup>3</sup> to 1.47 grams per meter<sup>3</sup>. Based on these initial ranges the Company is estimating that the amount of gold on Gorilla could be in excess of 300,000 ounces (or $500,000,000 at current gold prices); however, additional testing is necessary to determine the total size of the gold deposits and the amount of usable land. A copy of the geological report can be found here: <a  href="http://us.lrd.yahoo.com/SIG=1bhfbbotg/EXP=1327585145/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=https%253A%252F%252Fdocs.google.com%252Fviewer%253Fa%253Dv%2526pid%253Dexplorer%2526chrome%253Dtrue%2526srcid%253D0B4T1iRDs4VPKODQzNjhlM2YtOWFlMC00MzVkLWEwNDgtNTcyNjIxZGU0OGFm%2526hl%253Den%26esheet=50131325%26lan=en-US%26anchor=Gorilla%2BReport%26index=3%26md5=100302a91ec31470759de38ca392d542">Gorilla Report</a>.</p>
<p>Between Gorilla and Graystone II, the Company has a total portfolio of 1,200 hectares (or 2,965.27 acres) or approximately 12,000,000 square meters (or 4.63 square miles) of mining claims in Peru. The Company estimates that the two claims could have in excess of 500,000 ounces of gold (or <a  href="http://us.lrd.yahoo.com/SIG=19gnl6la9/EXP=1327585145/**http%3A//cts.businesswire.com/ct/CT%3Fid=smartlink%26url=http%253A%252F%252Fwww.cmegroup.com%252Ftrading%252Fmetals%252Fprecious%252Fgold.html%26esheet=50131325%26lan=en-US%26anchor=%2524825%252C000%252C000%2Bat%2Bcurrent%2Bgold%2Bprices%26index=4%26md5=e9a960fe075299582a26e27a8d99360e">$825,000,000 at current gold prices</a>). The Company is expecting that only about 15% of the claims may be viable to mine. Based on 15% of the claims being viable, the Company estimates the revenue potential could be up to $125,000,000.</p>
<p>The Company expects to begin mapping the properties in the next few months. Once the mapping is completed, the Company will devise a plan for production and be able to determine the amount of the claims that are viable to mine. The mapping will also determine if the Company&#8217;s initial testing was conducted in an area that has a larger concentration of gold than the rest of the property.</p>
<p>The Company acquired 100% of Gorilla for $55,000. The Company owns the claim through its wholly owned subsidiary Grupo Mineral Inca (a Peruvian Corporation). The Company acquired Gorilla prior to GMI being a 100% owned subsidiary and is currently finalizing the paperwork to have the claim transferred into GMI&#8217;s name. The Company anticipates that it will need to raise up to $750,000 to acquire the equipment and build the necessary infrastructure to conduct mining operations on the claims. The Company expects that it could be mining on these claims for the next 20-25 years.</p>
<p>These results have not been independently verified and were conducted internally to assist in determining if the property contains gold values conducive to profitable extraction. When Company&#8217;s management evaluates any projects its assumes the market price of gold is $850 per ounce.</p>
<p>No proven (measured) or probable (indicated) reserves have been  established with respect to the Gorilla project. Any references to       estimated, potential and/or “inferred” reserves or resources, and any estimated values of such reserves, contained in the geological report, or set forth in any other communication (i) do not represent proven (measured) or probable (indicated) reserves within the meaning of Item 102 of Regulation S-K and the Commission’s Securities Act Industry Guide 7, and (ii) should not be relied upon by any person in evaluating the       Company’s prospects at the Gorilla project.</p>
<p><strong>About The Graystone Company.</strong> The Graystone Company, Inc. is a U.S.-based mining and exploration company focused on acquiring and developing gold and other mineral properties. The Company&#8217;s strategy is to build value for shareholders by the identification, acquisition and exploration of early-stage properties that show significant potential for the discovery of gold.</p>
<p><strong>Notice Regarding Forward-Looking Statements</strong> in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure  outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.</p>
<p>Contact:</p>
<div>
<div>The Graystone Company, Inc.<br />
Paul Howarth, 702-438-4100</div>
<div><a  href="mailto:info@graystone1.com">info@graystone1.com</a><br />
<a  href="http://www.graystone1.com">www.graystone1.com</a></div>
<div><cite>Please read our full Disclaimer here: <a  href="http://www.northstarstocks.com/disclaimer/">http://www.northstarstocks.com/disclaimer/</a><br />
Northstarstocks.com expects to be compensated by a third party for The Graystone Company [OTC:GYST] advertising services.</cite></div>
</div>
</div>
</div>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-its-bulk-sampling-on-gorilla-indicate-possibility-of-500000-ounces-of-gold/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[OTC:GYST] The Graystone Company Announces Acquires Additional Mining Concession in Peru and Announces Phase I Testing</title>
		<link>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-acquires-additional-mining-concession-in-peru-and-announces-phase-i-testing/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-acquires-additional-mining-concession-in-peru-and-announces-phase-i-testing/#comments</comments>
		<pubDate>Mon, 09 Jan 2012 17:34:08 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks News]]></category>
		<category><![CDATA[gorilla]]></category>
		<category><![CDATA[graystone inc]]></category>
		<category><![CDATA[Grupo]]></category>
		<category><![CDATA[GYST]]></category>
		<category><![CDATA[Inca]]></category>
		<category><![CDATA[Minero]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[OTC]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=14055</guid>
		<description><![CDATA[The Graystone Company Announces Acquires Additional Mining Concession in Peru and Announces Phase I Testing Symbol Price Change GYST.OB 0.26 +0.04 &#160; LIMA, Peru&#8211;(BUSINESS WIRE)&#8211;  The Graystone Company (OTC Bulletin Board: GYST), announced that its 100% owned subsidiary Grupo Minero Inca (a Peruvian Corporation) has claimed a additional mining concession in Peru. The new concession has been named [...]]]></description>
			<content:encoded><![CDATA[<div id="yui_3_3_0_1_1326130277826186">
<div id="yui_3_3_0_1_1326130277826185">
<h1>The Graystone Company Announces Acquires Additional Mining Concession in Peru and Announces Phase I Testing</h1>
</div>
</div>
<div id="yui_3_3_0_1_1326130277826198">
<div>
<div id="mediarelatedquotes">
<div>
<table id="yui_3_3_0_7_1326130277826468">
<thead>
<tr>
<th>Symbol</th>
<th>Price</th>
<th>Change</th>
</tr>
</thead>
<tbody>
<tr id="yui_3_3_0_7_1326130277826470">
<td><a  href="/q?s=gyst.ob">GYST.OB</a></td>
<td>0.26</td>
<td>+0.04</td>
</tr>
<tr>
<td colspan="3">
<div><a  href="/q?s=gyst.ob"><img title="" src="http://ichart.finance.yahoo.com/t?s=gyst.ob&amp;lang=en-US&amp;region=us" alt="" /></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
<p>&nbsp;</p>
</div>
<div id="yui_3_3_0_1_1326130277826197">
<div>
<div>
<p>LIMA, Peru&#8211;(BUSINESS WIRE)&#8211;  The Graystone Company (OTC Bulletin Board: GYST), announced that its 100% owned subsidiary Grupo Minero Inca (a Peruvian Corporation) has claimed a additional mining concession in Peru. The new concession has been named Graystone II and is 800 hectares (or 1,976.84 acres) or  approximately 8,000,000 square meters (or 3.08 square miles). The additional property is adjacent to the Company&#8217;s current mining property, Gorilla (aka Graystone I). The acquisition of the additional concession increases the Company&#8217;s total portfolio of properties to 1,200 hectares (or 2,965.27 acres) or approximately 12,000,000 square meters (or 4.63 square miles). Both Gorilla and Graystone II are owned 100% by the Company.</p>
<p>The Company has done preliminary testing on approximately 10-15% of Graystone II. The initial results indicate that the part of Graystone II       that was tested may contain as much as 20,000 ounces of gold (or $32,000,000 at $1,600 per ounce). Based on this information, the Company       has deemed it worthwhile to continue to test the remaining part of  Graystone II to determine the amount of gold on the entire property and to map the property for production. Once the testing and mapping are completed, the Company will have a plan for production and know how much of the property is viable to mine.</p>
<p>&#8220;The initial testing on Graystone II has been successful,&#8221; said Paul Howarth, Managing Director of The Graystone Company, &#8220;however we need to  continue to test the property and complete the feasibility study. We will conduct a feasibility study to determine how much of the property is economically minable. There will always be portions of projects that are not cost effective to mine. But to have such positive initial results this early into our projects is exciting and we are looking forward to moving these properties toward production.&#8221;</p>
<p>The proximity of Graystone II with Gorilla will allow the Company to maximize its resources in the area and provide the Company with base of       operations to mine both Gorilla and Graystone II.</p>
<p>The Company claimed Graystone II prior to GMI being a 100% owned subsidiary. The Company is currently finalizing the paperwork to have       the claims transferred into GMI&#8217;s name.</p>
<p>The Company is currently finalizing the internal report on the testing completed on Gorilla and expects to release the data soon.</p>
<p>No proven (measured) or probable (indicated) reserves have been established with respect to any project of The Graystone Company. Any references to estimated, potential and/or “inferred” reserves or resources, and any estimated values of such reserves, contained in the geological report, or set forth in any other communication (i) do not represent proven (measured) or probable (indicated) reserves within the meaning of Item 102 of Regulation S-K and the Commission’s Securities Act Industry Guide 7, and (ii) should not be relied upon by any personel in evaluating the Company’s prospects.</p>
<p><strong>About The Graystone Company.</strong> The Graystone Company, Inc. is a U.S.-based mining and exploration company focused on acquiring and developing gold and other mineral properties. The Company&#8217;s strategy is to build value for shareholders by the identification, acquisition and exploration of early-stage properties that show significant potential for the discovery of gold.</p>
<p><strong>Notice Regarding Forward-Looking Statements</strong> in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.</p>
<p>&nbsp;</p>
<div>
<div>Contact:</div>
<div>The Graystone Company, Inc.<br />
Paul Howarth, (702) 438-4100<br />
<a  href="mailto:info@graystone1.com">info@graystone1.com</a><br />
<a  href="http://www.graystone1.com">www.graystone1.com</a></div>
<div>
<div><cite><br />
Please read our full Disclaimer here: <a  href="http://www.northstarstocks.com/disclaimer/">http://www.northstarstocks.com/disclaimer/</a><br />
Northstarstocks.com expects to be compensated by a third party for The Graystone Company [OTC:GYST] advertising services.</cite></div>
</div>
</div>
</div>
</div>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-news/otcgyst-the-graystone-company-announces-acquires-additional-mining-concession-in-peru-and-announces-phase-i-testing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proteonomix Inc. [OTC:PROT]</title>
		<link>http://www.northstarstocks.com/featured-profiles/proteonomix-inc-otcprot/</link>
		<comments>http://www.northstarstocks.com/featured-profiles/proteonomix-inc-otcprot/#comments</comments>
		<pubDate>Fri, 21 Oct 2011 14:50:28 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Featured Profiles]]></category>
		<category><![CDATA[CVD]]></category>
		<category><![CDATA[OTC]]></category>
		<category><![CDATA[PROT]]></category>
		<category><![CDATA[stem cell]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=13937</guid>
		<description><![CDATA[  &#160;   Proteonomix Inc. [OTC:PROT] Proteonomix is a biotechnology company focused on developing therapeutics based upon use of human cells and their derivatives. The Proteonomix Family of companies includes Proteoderm, StromaCel, National Stem Cell, PRTMI, The Sperm Bank of New York and THOR BioPharma. Proteoderm, Inc. is wholly owned subsidiary that has developed an [...]]]></description>
			<content:encoded><![CDATA[<div>
<h3 style="text-align: center;"> </h3>
<p>&nbsp;</p>
</div>
<div style="text-align: center;"> <a  href="http://www.northstarstocks.com/wp-content/uploads/prot.jpg" class="thickbox no_icon" rel="gallery-13937" title="prot"><img class="aligncenter size-full wp-image-13939" title="prot" src="http://www.northstarstocks.com/wp-content/uploads/prot.jpg" alt="" width="468" height="156" /></a></div>
<p style="text-align: center;"><strong>Proteonomix Inc. [OTC:PROT]</strong></p>
<p style="text-align: center;">Proteonomix is a biotechnology company focused on developing therapeutics based upon use of human cells and their derivatives. The Proteonomix Family of companies includes Proteoderm, StromaCel, National Stem Cell, PRTMI, The Sperm Bank of New York and THOR BioPharma. Proteoderm, Inc. is wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel, Inc. develops therapeutic modalities for the treatment of Cardiovascular Disease (CVD). National Stem Cell, Inc. is Proteonomix&#8217;s subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (&#8220;PRTMI&#8221;) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.</p>
<p style="text-align: center;"><strong> </strong></p>
<h3 style="text-align: center;"><strong>The Proteonomix Mission</strong><br />
<strong><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image002.gif" alt="The Proteonomix Mission" width="150" height="150" /></strong></h3>
<p style="text-align: center;">Their mission is to focus upon the development of therapies based upon the use of human stem cells and their derivatives, particularly in the areas of diabetes and cardiac diseases. They primarily employ bone marrow, pancreatic, and umbilical cord blood derived cells in a process of identification, separation, expansion and delivery towards treatment of diseases previously considered incurable. It is their further goal to deliver these therapies to the widest possible spectrum of patients both geographically and economically in the minimum time.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;"><strong>Primary Focus</strong></h3>
<p style="text-align: center;">They are primarily focused on developing therapies and products based upon the use of human stem cells and their derivatives with an initial focus on diabetes and cardiac diseases.<br />
<img src="http://www.smallcapsociety.com/profile_images/prot/clip_image004.jpg" alt="http://www.proteonomix.com/images/headless-doctor.png" width="150" height="150" /><br />
<strong>Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable.</strong><br />
Many of the currently incurable diseases associated with aging are caused by the degeneration of specific cell types in the body. These diseases include but are not limited to cancer, heart disease, diabetes, and autoimmune conditions. Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable.</p>
<p style="text-align: center;"><strong>StromaCel™ Cardiac Treatment</strong><br />
They are developing their Post Myocardial Infarction treatment, StromaCel™. This treatment is taken intravenously in the first 14 days following an infarction to assist to rebuild the underlying vascular tissuein order to increase cardiac muslcle recovery. They are currently seeking funding to make application for FDA Clinical trials on this promising treatment.</p>
<p style="text-align: center;"><strong>Diabetes Research</strong><br />
They have been in research and development for many years on a treatment for all forms of diabetes. Recent breakthroughs in their research have encouraged us to seek funding for large animal trials in anticipation of Phase 1 trials to follow.</p>
<p style="text-align: center;"><strong>Other Areas of Development</strong><br />
Proteonomix also looks at overall health and wellness. As their Proteoderm products comes to market for skin rejuvination and anti-aging, we are also developing additional products to improve the quality of their clients lives.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;">Management</h3>
<h3 style="text-align: center;"><strong>Michael Cohen</strong></h3>
<h3 style="text-align: center;">President, Chief Executive Officer, Chairman of the Board</h3>
<p style="text-align: center;">Michael Cohen has served as their President, Chief Executive Officer and Chairman of their board of directors since September 12, 2006. Michael Cohen began his career as a paramedic for NYC EMS in 1989. He joined Americorp Securities as a Vice President in its mergers and acquisitions department in 1994. He was instrumental in launching a number of successful IPOs at Americorp Securities. He was recruited by Dafna Construction in 1995 as its CFO and played a principal role in its growth and subsequent purchase. In 1997, Mr. Cohen joined Citigroup as a Vice President of Corporate Finance and managed a department in the risk management division of Salomon Smith Barney. In 2002, Mr. Cohen founded National Stem Cell Inc, their operating subsidiary. Mr. Cohen serves as our Chairman of the Board and President as well as the Principal Investigator for most of their therapeutic developments. Mr. Cohen attended Skidmore College and graduated with a Bachelor of Science from Haifa University in 1988.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;">Ian McNiece</h3>
<h3 style="text-align: center;">Ph.D., Chief Scientific Officer, Director</h3>
<p style="text-align: center;">Dr. McNiece received his PhD in 1986 from the University of Melbourne undertaking his thesis work in studies of blood cell development at the Peter MacCallum Cancer Institute in Melbourne, Australia. He moved to the USA in July of 1986 to the University of Virginia as a postdoctoral fellow. In August 1998 he started working at Amgen Inc, as a Research Scientist and then as a Laboratory Head. In September 1997, he left Amgen and moved to the University of Colorado as the Director of Research in the Bone Marrow Transplant Program. Subsequently, he moved to Johns Hopkins University as a Professor of Oncology and Laboratory Director of the Graft Engineering Laboratory from January 2003 to May 2007. This laboratory is responsible for all processing of bone marrow, peripheral blood progenitor cell (PBPC) products and cord blood products for transplantation of cancer patients. He was actively involved in optimization of cellular grafts for patient treatment and the translation of basic research to clinical treatment. In July, 2007 he joined the Stem Cell Institute at the University of Miami as Director of the Experimental and Clinical Cell-Based Therapies and is presently Professor of Medicine at the University of Miami.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;">Jason Isaacs</h3>
<h3 style="text-align: center;">Secretary</h3>
<p style="text-align: center;">Jason Isaacs joined as Secretary in June of 2010. Mr. Isaacs brings over thirteen years of legal experience. Mr. Isaacs is General Counsel of Green Hills Software, Inc., the largest independent provider of real time operating systems and embedded software development tools. Mr. Isaacs has a wide base of legal experience managing and protecting intellectual property resources, negotiating technology transactions with major corporations and governments, and complying with applicable laws and regulations. Mr. Isaacs practiced law at Brobeck Phleger &amp; Harrison LLP and Heller Ehrman LLP in San Diego, specializing in technology transactions, licensing arrangements and business litigation in his representation of high growth and venture backed companies. Mr. Isaacs received his law degree from Harvard Law School, cum laude, and a B.A. from Brown University, magna cum laude, Phi Beta Kappa.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;">Steven Byle</h3>
<h3 style="text-align: center;">Director</h3>
<p style="text-align: center;">Steven Byle joined their board of directors on January 5, 2009. Mr. Byle brings twenty years of experience in technology development and corporate management in the international market.  Mr. Byle is a successful entrepreneur, engineer, and patent attorney for a diverse array of international, public and private, ventures. Mr. Byle is presently the Vice President of Technology for Dockwise, a public energy services company on the Euronext Amsterdam exchange (DOCKW:NA) with annual revenues exceeding US $500 million.  Mr. Byle is also a founder and Member of the Board for a diverse group of companies, including: Pantheon Energy, an alternative energy company in Europe, Core International Group, a Cyprus company performing international manufacturing, logistics and distribution with plants in India and Malaysia, and Texas Auto Superstore, an online auto dealer in the United States. Mr. Byle speaks Spanish and Mandarin Chinese fluently, holds a J.D. degree with Honors in law from the University of Texas School of Law, specializing in Intellectual Property Law, and holds a B.S. degree in Engineering from the University of Michigan, summa cum laude as a prestigious Angell Scholar.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;">Roger Fidler Esq.</h3>
<h3 style="text-align: center;">Corporate Council</h3>
<p style="text-align: center;">Mr. Fidler has been engaged in the private practice of law since 1983, specializing in corporate and securities law. Mr. Fidler was the sole director, President, Chief Executive and Financial Officer of Global Agri-Med Technologies, Inc., a corporation that is publicly traded in the pink sheets, since inception in October 28, 1999 until January 11, 2010. Mr. Fidler has previously served on the Boards of Directors and as an officer of several other publicly held corporations, including Diehl Graphsoft, Inc., D-Lanz Development Group, Inc., the Leonard Swindbourne Acquisition Corp., and numerous private companies. Mr. Fidler received a B.S. degree in Physics from Dickinson College, Carlisle, Pennsylvania in 1972; a Masters of Science degree from the University of Illinois at Champaign-Urbana, Illinois in 1974; and a Juris Doctor from the University of South Carolina in 1977 where he was a member of the Law Review. He is a member of the bars of New Jersey, New York and the District of Columbia and has practiced before the federal and state courts in New York and New Jersey as well as pro hac vice in cases before Federal District Courts in Kentucky and Florida. In addition he is a patent attorney authorized to practice before the United States Patent and Trademark Office.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;"><strong>Intellectual Properties and Patent Applications.</strong></h3>
<p style="text-align: center;"><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image008.jpg" alt="Patent Applications" width="150" height="150" /></p>
<p style="text-align: center;">Through their operating subsidiary, National Stem Cell, we have developed a catalog of intellectual properties and patent applications. These technologies are designed to work together in a synergistic fashion. Their initial focus in stem cell therapeutics is to achieve a leadership position in:</p>
<p style="text-align: center;"><strong>The Development of Identification Biomarkers </strong><br />
A biomarker is a substance used as an indicator of a biological state which refers to the complete range of genes found in biological structure and processes of the living body, including the nervous system, the endocrine system, and their senses of sight, hearing, taste, smell, and touch. It is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention) cell derivatives, and cellular proteins.</p>
<p style="text-align: center;"><strong>Expansion Technology</strong><br />
Proteonomix is developing a unique growth medium that allows expansion far beyond the traditional 10:1 achieved in conventional methods before cellular replication errors make it nonviable. This technology is of benefit to any treatment or process that might be improved by drastically increased concentrations or numbers of cells.</p>
<p style="text-align: center;"><strong>Cryopreservation</strong><br />
Proteonomix is developing an innovative cryopreservation technique resulting in substantial reduction in lost cells during the freezing and thawing process. This technology is of benefit where it is advantageous to store cellular material for later use, to maintain stock, or to perform long distance transportation.</p>
<p style="text-align: center;"><strong>Anti-Inflammatory</strong><br />
Proteonomix&#8217;s StromaCel™ cellular materials has given some indications as a general anti-inflammatory. We are looking for partners wishing to explore this indication for conditions other than myocardial infarction</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;"><strong>Diabetes Research</strong></h3>
<p style="text-align: center;" align="center"><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image010.jpg" alt="Testing to be done" width="540" height="95" /></p>
<p style="text-align: center;"><strong>Cells that they are able to isolate will substantially reduce rejection when transplanted into the liver of the same diabetic patient.</strong><br />
They have identified stem cells in the human pancreas and have applied for patents for cell surface markers (the molecules present on the surface of each cell which define the cell on what receptors are present &#8211; a technique often used to associate cells with certain immune functions) for these pancreatic stem cells as well as methods for their isolation.</p>
<p>Based on the fact that these cells are autologous (from same person) rather than from a non-related donor, they anticipate that the cells that they are able to isolate will substantially reduce rejection when transplanted into the liver of the same diabetic patient. The company is performing further research in this area with the University of Miami.</p>
<h3 style="text-align: center;"> </h3>
<h3 style="text-align: center;"><strong>AFFILIATES</strong></h3>
<p style="text-align: center;" align="center"><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image012.jpg" alt="PRTMI Model Partnerships" width="540" height="95" /></p>
<p style="text-align: center;"><strong>Clinical Applications of Regenerative Medicine.<br />
Proteonomix Institutes</strong></p>
<p style="text-align: center;" align="center"><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image014.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image1.png" width="178" height="178" /><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image016.gif" alt="http://www.proteonomix.com/images/Test%20Images2/image3.png" width="178" height="178" /><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image018.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image2.png" width="178" height="178" /></p>
<p style="text-align: center;">Proteonomix is presently forming an international network of Stem Cell Laboratories, following their proprietary Proteonomix Regenerative Translational Medicine Institute (PRTMI) business model.</p>
<p style="text-align: center;">These institutes focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. The mission of these Institutes is to provide a seamless transition between Proteonomix&#8217;s laboratory activities and the local patient care facility. This involves development of clinical protocols, manufacturing of cellular materials for clinical use, monitoring compliance of clinical trials while participating on a global level in these processes.</p>
<p style="text-align: center;" align="center"><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image020.jpg" alt="PRTMI Model Partnerships" width="540" height="95" /></p>
<h3 style="text-align: center;"><strong>Distribution of Anti-Aging and Wound Care Products.</strong></h3>
<p style="text-align: center;"><strong>Proteoderm Dermatologist</strong><br />
<strong>Their subsidiary, Proteoderm is currently forming a network of dermatologist for the distribution of its anti-aging and wound care products. </strong></p>
<p style="text-align: center;" align="center"><strong><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image022.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image6.png" width="178" height="178" /><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image024.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image4.png" width="178" height="178" /><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image026.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image5.png" width="178" height="178" /></strong></p>
<p style="text-align: center;">The networks are expected to activate in the fourth quarter 2010 in the United States and first quarter 2011 in the UAE and regional GCC countries.</p>
<p style="text-align: center;">For information on becoming a network doctor, or to inquire about starting your own network in a region that is currently not served, please contact us.</p>
<p style="text-align: center;" align="center"><strong><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image028.jpg" alt="PRTMI Model Partnerships" width="540" height="95" /></strong></p>
<p style="text-align: center;"><strong>Joint Research in Clinical Exploration</strong><br />
<strong>Proteonomix&#8217;s Technologies</strong></p>
<p style="text-align: center;" align="center"><strong><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image030.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image7.png" width="178" height="178" /><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image032.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image9.png" width="178" height="178" /><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image034.jpg" alt="http://www.proteonomix.com/images/Test%20Images2/image8.png" width="178" height="178" /></strong></p>
<p style="text-align: center;"><strong>Their technologies have potential efficacy and usefulness in a wide range of applications. They are currently looking for owners of complementary technologies for joint research or affiliates interested in clinical exploration of additional indications for their own technologies.</strong></p>
<p style="text-align: center;"><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image036.jpg" alt="Proteoderm" width="116" height="116" /></p>
<p style="text-align: center;"><strong>Expansion Technology: </strong>Proteonomix is developing a unique growth medium that allows expansion far beyond the traditional 10:1 achieved in conventional methods before cellular replication errors make it nonviable. This technology is of benefit to any treatment or process that might be improved by drastically increased concentrations or numbers of cells.</p>
<p style="text-align: center;"><strong><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image038.jpg" alt="StromaCel" width="116" height="116" /></strong></p>
<p style="text-align: center;"><strong>Cryopreservation:</strong> Proteonomix is developing an innovative cryopreservation technique resulting in substantial reduction in lost cells during the freezing and thawing process. This technology is of benefit where it is advantageous to store cellular material for later use, to maintain stock, or to perform long distance transportation.</p>
<p style="text-align: center;"><strong><img src="http://www.smallcapsociety.com/profile_images/prot/clip_image040.jpg" alt="Diabetes" width="116" height="116" /></strong></p>
<p style="text-align: center;"><strong>Anti-Inflammatory:</strong> Proteonomix&#8217;s StromaCel™ cellular materials has given some indications as a general anti-inflammatory. They are looking for partners wishing to explore this indication for conditions other than myocardial infarction.<strong> </strong></p>
<p><strong></strong> </p>
<p>Please read our full Disclaimer here: <a  href="http://www.northstarstocks.com/disclaimer/">http://www.northstarstocks.com/disclaimer/</a><br />
Northstarstocks.com expects to be compensated by a third party for Proteonomix Inc. [OTC:PROT] advertising services.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/featured-profiles/proteonomix-inc-otcprot/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[OTC:PROT] to Move Forward With Offshore Stem Cell Testing</title>
		<link>http://www.northstarstocks.com/northstar-stocks-news/otcprot-to-move-forward-with-offshore-stem-cell-testing/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-news/otcprot-to-move-forward-with-offshore-stem-cell-testing/#comments</comments>
		<pubDate>Wed, 19 Oct 2011 21:58:02 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks News]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[human cells]]></category>
		<category><![CDATA[PROT]]></category>
		<category><![CDATA[proteonomix]]></category>
		<category><![CDATA[PRTMI]]></category>
		<category><![CDATA[stem cell]]></category>
		<category><![CDATA[stromacel]]></category>
		<category><![CDATA[therapeutics]]></category>
		<category><![CDATA[UMK-121]]></category>

		<guid isPermaLink="false">http://www.northstarstocks.com/?p=13918</guid>
		<description><![CDATA[Proteonomix, Inc. (PROT) to Move Forward With Offshore Stem Cell Testing Symbol Price Change PROT.OB 0.72 +0.07     Press Release Source: Proteonomix On Wednesday October 19, 2011, 4:45 pm MOUNTAINSIDE, NJ&#8211;(Marketwire -10/19/11)- PROTEONOMIX, INC. (OTC.BB: PROT.OB &#8211; News), a biotechnology company focused on developing therapeutics based upon the use of human cells and their [...]]]></description>
			<content:encoded><![CDATA[<div>
<div id="y-article-hd">
<h1 style="text-align: center;">Proteonomix, Inc. (PROT) to Move Forward With Offshore Stem Cell Testing</h1>
</div>
<div id="y-article-bd">
<div style="text-align: center;">
<div id="y-article-related" style="text-align: center;">
<div id="yfi_market_summary">
<div>
<table id="yfi_ms_accordion">
<thead>
<tr>
<th scope="col">Symbol</th>
<th scope="col">Price</th>
<th scope="col">Change</th>
</tr>
</thead>
<tbody>
<tr>
<th scope="row"><a  href="http://finance.yahoo.com/q?s=PROT.OB">PROT.OB</a></th>
<td>0.72</td>
<td>+0.07</td>
</tr>
<tr>
<td colspan="3">
<div><a  href="http://finance.yahoo.com/q?s=PROT.OB"><img title="Chart for PROTEONOMIX INC" src="http://chart.finance.yahoo.com/instrument/1.0/PROT.OB/chart;range=1d/image;size=239x110?lang=en-US&amp;region=US" alt="Chart for PROTEONOMIX INC" width="239" height="110" /></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
<p style="text-align: center;"> </p>
<div id="ypf-article-related"> </div>
</div>
<div style="text-align: center;"><strong>Press Release</strong> Source: Proteonomix On Wednesday October 19, 2011, 4:45 pm</div>
<p style="text-align: center;">MOUNTAINSIDE, NJ&#8211;(Marketwire -10/19/11)- PROTEONOMIX, INC. (OTC.BB: <a  href="http://finance.yahoo.com/q?s=prot.ob">PROT.OB</a> &#8211; <a  href="http://finance.yahoo.com/q/h?s=prot.ob">News</a>), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it intends to move forward with the testing of its <a  href="http://us.lrd.yahoo.com/SIG=14k9ctntq/EXP=1320269380/**http%3A//ctt.marketwire.com/%3Frelease=811495%26id=894688%26type=1%26url=http%253a%252f%252fwww.proteonomix.com%252ftechnology.htm">StromaCel technology</a> through its <a  href="http://us.lrd.yahoo.com/SIG=14kngbdh8/EXP=1320269380/**http%3A//ctt.marketwire.com/%3Frelease=811495%26id=894691%26type=1%26url=http%253a%252f%252fwww.proteonomix.com%252faffiliates.htm">PRTMI subsidiary</a> or its affiliates. The Company decided to examine the possibility of testing its cardiac stem cell treatment offshore in light of the progress toward its trial of UMK-121, its stem cell treatment for patients awaiting liver transplant to overcome End Stage Liver Disease (&#8220;ESLD&#8221;), in the United States.</p>
<p style="text-align: center;">Michael Cohen, President of the Company, stated: &#8220;Since we progress toward the commencement of our trial of UMK-121 in the United States, we have decided to explore the possible testing of our cardiac treatment offshore in order to reduce the cost of bringing the cardiac treatment to market. This strategic decision is being made in recognition of the increasing costs associated with bringing a new drug to market in the United States through the NDA (New Drug Application) process and the availability of expert medical testing capabilities offshore at a fraction of the cost.&#8221;</p>
<p style="text-align: center;">Mr. Cohen continued: &#8220;Once we have established the efficacy of our cardiac stem cell treatment offshore and have commenced foreign sales, then we will be in a better financial position to pursue the NDA in the United States.&#8221; We have been approached by one group that has expressed interest in exploring such a possibility and we will follow through with this in the coming weeks. Meanwhile, we will seek out others interested in a similar transaction keeping in mind at all times that any such deal would have to provide immediate benefit to our shareholders.&#8221;</p>
<p style="text-align: center;">About Proteonomix, Inc.:</p>
<p style="text-align: center;">Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Proteonomix Family of companies includes Proteoderm, StromaCel, National Stem Cell, PRTMI and THOR Biopharma. Proteoderm, Inc. is a wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel, Inc. develops therapeutic modalities for the treatment of Cardiovascular Disease (CVD). National Stem Cell, Inc. is Proteonomix&#8217;s operating subsidiary. Proteonomix Regenerative Translational Medicine Institute, Inc. (&#8220;PRTMI&#8221;) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit <a  href="http://us.lrd.yahoo.com/SIG=146kpgjvt/EXP=1320269380/**http%3A//ctt.marketwire.com/%3Frelease=811495%26id=894694%26type=1%26url=http%253a%252f%252fwww.proteonomix.com%252f">http://www.proteonomix.com/</a>, <a  href="http://us.lrd.yahoo.com/SIG=145efo24j/EXP=1320269380/**http%3A//ctt.marketwire.com/%3Frelease=811495%26id=894697%26type=1%26url=http%253a%252f%252fwww.proteoderm.com%252f">http://www.proteoderm.com/</a>, <a  href="http://us.lrd.yahoo.com/SIG=140vnhora/EXP=1320269380/**http%3A//ctt.marketwire.com/%3Frelease=811495%26id=894700%26type=1%26url=http%253a%252f%252fwww.otcqb.com%252f">http://www.otcqb.com/</a> and <a  href="http://us.lrd.yahoo.com/SIG=13umm92s6/EXP=1320269380/**http%3A//ctt.marketwire.com/%3Frelease=811495%26id=894703%26type=1%26url=http%253a%252f%252fwww.sec.gov%252f">http://www.sec.gov/</a>.</p>
<p style="text-align: center;">Forward-looking statements:</p>
<p style="text-align: center;">Certain statements contained herein are &#8220;forward-looking statements&#8221; (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at the time statements are made.</p>
<p style="text-align: center;">Please read our full Disclaimer here: <a  href="http://www.northstarstocks.com/disclaimer/">http://www.northstarstocks.com/disclaimer/</a><br />
Northstarstocks.com expects to be compensated by a third party for Proteonomix Inc. [OTC:PROT] advertising services.</p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-news/otcprot-to-move-forward-with-offshore-stem-cell-testing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Join Our Newsletter</title>
		<link>http://www.northstarstocks.com/northstar-stocks-newsletter/join-our-newsletter/</link>
		<comments>http://www.northstarstocks.com/northstar-stocks-newsletter/join-our-newsletter/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 14:49:54 +0000</pubDate>
		<dc:creator>northstarstocks</dc:creator>
				<category><![CDATA[Northstar Stocks Newsletter]]></category>

		<guid isPermaLink="false">http://northstarstocks.com/?p=13207</guid>
		<description><![CDATA[Join the Northstar Stocks Alert Newsletter! A Better Wealth Of Information Click Here To Join Today]]></description>
			<content:encoded><![CDATA[<h3 style="text-align: center;">Join the Northstar Stocks Alert Newsletter!</h3>
<p style="text-align: center;">A Better Wealth Of Information</p>
<h2 style="text-align: center;"><a  href="http://northstarstocks.com/newsletter/"><img class="aligncenter size-full wp-image-13235" title="newsletter join" src="http://64.207.157.174/wp-content/uploads/newsletter-join.jpg" alt="newsletter join" width="350" height="281" /></a></h2>
<h2 style="text-align: center;"><a  href="/newsletter/">Click Here To Join Today</a></h2>
]]></content:encoded>
			<wfw:commentRss>http://www.northstarstocks.com/northstar-stocks-newsletter/join-our-newsletter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

